103 related articles for article (PubMed ID: 21215765)
1. Synthesis of some novel androstanes as potential aromatase inhibitors.
Yadav MR; Sabale PM; Giridhar R; Zimmer C; Haupenthal J; Hartmann RW
Steroids; 2011 Apr; 76(5):464-70. PubMed ID: 21215765
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of new A,D-ring modified steroids as aromatase inhibitors: design, synthesis, and biological activity evaluation.
Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
J Med Chem; 2005 Oct; 48(20):6379-85. PubMed ID: 16190763
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors.
Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of a series of A,B-ring modified 16,17-secoandrostane derivatives.
Sakac M; Gaković A; Stojanović S; Djurendić E; Kojić V; Bogdanović G; Gasi KP
Bioorg Chem; 2008 Jun; 36(3):128-32. PubMed ID: 18304603
[TBL] [Abstract][Full Text] [Related]
5. New structure-activity relationships of A- and D-ring modified steroidal aromatase inhibitors: design, synthesis, and biochemical evaluation.
Varela C; Tavares da Silva EJ; Amaral C; Correia da Silva G; Baptista T; Alcaro S; Costa G; Carvalho RA; Teixeira NA; Roleira FM
J Med Chem; 2012 Apr; 55(8):3992-4002. PubMed ID: 22475216
[TBL] [Abstract][Full Text] [Related]
6. Steroidal pyrazolines evaluated as aromatase and quinone reductase-2 inhibitors for chemoprevention of cancer.
Abdalla MM; Al-Omar MA; Bhat MA; Amr AG; Al-Mohizea AM
Int J Biol Macromol; 2012 May; 50(4):1127-32. PubMed ID: 22361454
[TBL] [Abstract][Full Text] [Related]
7. Lead optimization providing a series of flavone derivatives as potent nonsteroidal inhibitors of the cytochrome P450 aromatase enzyme.
Gobbi S; Cavalli A; Rampa A; Belluti F; Piazzi L; Paluszcak A; Hartmann RW; Recanatini M; Bisi A
J Med Chem; 2006 Jul; 49(15):4777-80. PubMed ID: 16854084
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and study of some new N-substituted imide derivatives as potential anticancer agents.
Jindal DP; Bedi V; Jit B; Karkra N; Guleria S; Bansal R; Palusczak A; Hartmann RW
Farmaco; 2005 Apr; 60(4):283-90. PubMed ID: 15848202
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, antitumor activity and molecular docking study of novel benzofuran-2-yl pyrazole pyrimidine derivatives.
El-Zahar MI; Adb El-Karim SS; Haiba ME; Khedr MA
Acta Pol Pharm; 2011; 68(3):357-73. PubMed ID: 21648190
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 4-imidazolylflavans as nonsteroidal aromatase inhibitors.
Pouget C; Yahiaoui S; Fagnere C; Habrioux G; Chulia AJ
Bioorg Chem; 2004 Dec; 32(6):494-503. PubMed ID: 15530990
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of azole isoflavone inhibitors of aromatase.
Hackett JC; Kim YW; Su B; Brueggemeier RW
Bioorg Med Chem; 2005 Jun; 13(12):4063-70. PubMed ID: 15911319
[TBL] [Abstract][Full Text] [Related]
12. Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors.
Yahiaoui S; Pouget C; Buxeraud J; Chulia AJ; Fagnère C
Eur J Med Chem; 2011 Jun; 46(6):2541-5. PubMed ID: 21497425
[TBL] [Abstract][Full Text] [Related]
13. New Potent 5α- Reductase and Aromatase Inhibitors Derived from 1,2,3-Triazole Derivative.
El-Naggar M; El-All ASA; El-Naem SIA; Abdalla MM; Rashdan HRM
Molecules; 2020 Feb; 25(3):. PubMed ID: 32033281
[TBL] [Abstract][Full Text] [Related]
14. Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids.
Takahashi M; Yamashita K; Numazawa M
Steroids; 2010 Apr; 75(4-5):330-7. PubMed ID: 20096721
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of DL-standishinal and its related compounds for the studies on structure-activity relationship of inhibitory activity against aromatase.
Katoh T; Akagi T; Noguchi C; Kajimoto T; Node M; Tanaka R; Nishizawa née Iwamoto M; Ohtsu H; Suzuki N; Saito K
Bioorg Med Chem; 2007 Apr; 15(7):2736-48. PubMed ID: 17287126
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of aminoglutethimide: structure/activity relationships and receptor interactions.
Nicholls PJ; Daly MJ; Smith HJ
Breast Cancer Res Treat; 1986; 7 Suppl():S55-67. PubMed ID: 3755630
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel steroidal D-ring substituted isoxazoline derivatives of 17-oxoandrostanes.
Banday AH; Singh S; Alam MS; Reddy DM; Gupta BD; Sampath Kumar HM
Steroids; 2008 Mar; 73(3):370-4. PubMed ID: 18166206
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroids.
Bansal R; Thota S; Karkra N; Minu M; Zimmer C; Hartmann RW
Bioorg Chem; 2012 Dec; 45():36-40. PubMed ID: 23064126
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors.
Pingaew R; Prachayasittikul V; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Bioorg Med Chem; 2015 Jul; 23(13):3472-80. PubMed ID: 25934226
[TBL] [Abstract][Full Text] [Related]
20. Facile synthesis of chrysin-derivatives with promising activities as aromatase inhibitors.
Mohammed HA; Ba LA; Burkholz T; Schumann E; Diesel B; Zapp J; Kiemer AK; Ries C; Hartmann RW; Hosny M; Jacob C
Nat Prod Commun; 2011 Jan; 6(1):31-4. PubMed ID: 21366040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
